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Objective: To study the effects of dexmedetomidine on cerebral injury, inﬂammation,
oxidative stress and renal function of patients with diabetes mellitus type 2 complicated
with acute cerebral hemorrhage.
Methods: A total of 98 cases who had been diagnosed with diabetes mellitus type 2
complicated with acute cerebral hemorrhage and treated with interventional therapy in
Xin Hua Hospital Afﬁliated to Shanghai Jiao Tong University School of Medicine from
September 2014 January 2016 were chosen to be our study subjects. Among them, 50
cases given dexmedetomidine treatment in the process of anesthesia were included in the
dexmedetomidine group (Group A), while the other 48 cases treated with equal amount of
normal saline were considered as the negative control group. The postoperative cerebral
injury indexes and the serum biochemical indexes were detected after 24 h.
Results: The contents of serum S100b [(2.1 ± 0.2) mg/L] and neuron-speciﬁc enolase
(NSE) [(14.2 ± 1.3) mg/mL] in Group A were all signiﬁcantly lower than serum S100b
[(2.9 ± 0.3) mg/L] and NSE [(16.6 ± 1.7) mg/mL] of patients in negative control group.
The contents of cerebrospinal ﬂuid S100b [(0.9 ± 0.1) mg/L] and NSE [(10.7 ± 1.3) mg/
mL] in Group A were all signiﬁcantly lower than cerebrospinal ﬂuid S100b
[(1.3 ± 0.2) mg/L] and NSE [(15.3 ± 1.7) mg/mL] of patients in negative control group.
The contents of erythrocyte sedimentation rate [(11.7 ± 2.5) mm/h], c-reactive protein
[(2.3 ± 0.4) mg/L], urea nitrogen [(10.7 ± 1.2) mmol/L] and serum creatinine
[(151.6 ± 14.9)] mmol/L in Group A were all signiﬁcantly lower than erythrocyte sedi-
mentation rate [(23.6 ± 3.8) mm/h], c-reactive protein [(6.9 ± 1.1) mg/L], urea nitrogen
[(16.7 ± 1.7) mmol/L] and serum creatinine [(192.5 ± 18.3)] mmol/L of patients in
negative control group.
Conclusions: The application of dexmedetomidine in the interventional therapy of
diabetes mellitus type 2 complicated with acute cerebral hemorrhage could protect brain
and renal functions and reduce systemic inﬂammatory responses.1. Introduction
Diabetes is a kind of common metabolic disorders charac-
terized by a systemically chronic progressive increase of bloodsugar level. Due to its long disease course, it can easily lead to
metabolic disorders and affect systems of heart, renal, eye, nerve
and so on. Cerebrovascular disease is one of the common
complications of diabetes with an incidence rate of 20%–40%.
The basic pathological of the disease is atherosclerosis[1–3]. In
recent years, people have paid more and more attentions to the
effect of dexmedetomidine on sedating, controlling the stress
response and inhibiting the apoptosis of nerve cells in the
perioperative period which has been used in the management
and the protection of nerve function in the perioperative
period of neurosurgical operation[4,5]. This study aimed to
discuss the application and value of dexmedetomidine in
patients with diabetes mellitus type 2 complicated with acute
cerebral hemorrhage during the perioperative period.article under the CC BY-NC-ND license (http://
Table 1
Postoperative renal function indexes of patients in Group A and NC
group.
Parameters Group A (n = 50) NC group (n = 48) P
ESR (mm/h) 11.7 ± 2.5 23.6 ± 3.8 < 0.05
CRP (mg/L) 2.3 ± 0.4 6.9 ± 1.1 < 0.05
BUN (mmol/L) 10.7 ± 2.1 16.7 ± 2.8 < 0.05
Cr (mmol/L) 151.6 ± 30.4 192.5 ± 29.3 < 0.05
AST (IU/L) 12.3 ± 2.3 11.8 ± 2.5 > 0.05
ALT (IU/L) 15.8 ± 3.1 14.3 ± 2.7 > 0.05
CK (mmol/L) 214.3 ± 35.8 231.8 ± 40.7 > 0.05
CK-MB (mmol/L) 11.2 ± 2.5 10.9 ± 2.1 > 0.05
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2.1. Clinical data
A total of 98 patients who had been diagnosed with diabetes
mellitus type 2 complicated with acute cerebral hemorrhage,
given interventional therapy in Xin Hua Hospital Afﬁliated to
Shanghai Jiao Tong University School of Medicine from
September 2014 to January 2016 and met the following inclu-
sion criteria were selected to be the study subjects. The inclusion
criteria required that the chosen patients should show the ﬁrst-
ever cerebral hemorrhage, have a history of diabetes and be
treated with surgical intervention, while patients with severe
hepatic and renal dysfunction, history of mental illnesses and
long-term application of opioid drugs would be excluded. This
study was conﬁrmed and approved by the Ethics Committee of
our hospital and consents from the selected patients and their
families were obtained.
The endpoint of all the selected patients was conducted for 1
week after surgery. Patients given dexmedetomidine treatment in
the process of anesthesia were included in the dexmedetomidine
group (Group A), while patients treated with equal amount of
normal saline were included in the negative control group (NC
group).
2.2. Experimental methods
According to the process that whether patients were treated
with dexmedetomidine during surgery or not, those 98 patients
were divided into two groups. Patients given dexmedetomidine
were regarded as Group A (n = 50), while patients without
dexmedetomidine were considered as NC group (n = 48). All
selected patients received routine anesthetic induction (mid-
azolam, propofol, atracurium, etomidate, fentanyl); laryngeal
masks were placed to manage their airways and 1%–2% sev-
oﬂurane was used to maintain anesthesia in the operation. At
5 min before the operation, dexmedetomidine (0.5 mg/kg/h) was
infused intravenously in patients in Group A, which would stop
at 20 min before the surgery was ﬁnished. Patients in NC group
were given equal amount of normal saline by the same way. On
24 h after surgery, 5 mL peripheral venous blood and 2 mL
cerebrospinal ﬂuid samples of patients in the two groups were
collected. Chemiluminescence immunoassay was used to test
the contents of S100b and neuron-speciﬁc enolase (NSE).
ELISA was used to determine the c-reactive protein (CRP)
content; Westergren method was applied to examine erythro-
cyte sedimentation rate (ESR); fully automatic biochemistry
analyzer was employed to detect blood urea nitrogen (BUN),
serum creatinine (Cr), aspartate aminotransferase (AST) and
alanine aminotransferase (ALT); and myocardial enzyme
spectrum detection was used to detect the contents of creatine
kinase (CK) and CK-MB.
2.3. Statistical methods
The experimental data were typed and analyzed by SPSS
20.0.0. Measurement data were expressed by mean ± SD and
analyzed by t-test and enumeration data were presented by fre-
quency and analyzed by Chi-square test. Differences were sta-
tistically signiﬁcant (P < 0.05).3. Results
3.1. General data of the study subjects
Among those 98 cases, 50 of them were treated with dex-
medetomidine. They were included in Group A. In Group A, 29
cases were males and 21 were females aging from (51 ± 6)
years with a body mass index (BMI) of (24.2 ± 2.8) kg/m2,
preoperative blood glucose of 8–15 mmol/L [the average was
(11.2 ± 0.8) mmol/L], disease courses of diabetes of 8–15 years
[the average was (11.7 ± 1.5) years] and Glasgow coma scale
(GCS) of 5–9 scores [the average was (6.8 ± 0.7) scores]. The
other 48 cases were not treated with dexmedetomidine in the
process of anesthesia. They were included in NC group. In NC
group, 27 cases were males and 21 were females aging from
(53 ± 5) years with a BMI of (24.6 ± 2.5) kg/m2, preoperative
blood glucose of 9–16 mmol/L [the average was (11.9 ± 1.2)
mmol/L], disease courses of diabetes of 7–13 years [the average
was (10.9 ± 1.7) years], GCS of 6–9 scores [the average was
(6.7 ± 0.6) scores]. After statistically analyzing, it was found
that the levels of genders, ages, BMI, blood glucose, disease
courses, and GCS of the two groups showed no differences
(P > 0.05).
3.2. Brain injury indexes
The serum indexes S100b of brain injury [(2.1 ± 0.2) mg/L]
and NSE [(14.2 ± 1.3) mg/mL] of patients in the Group A were
all signiﬁcantly lower than those [(2.9 ± 0.3) mg/L and
(16.6 ± 1.7) mg/mL, respectively] of patients in the NC group.
Moreover, their cerebrospinal ﬂuid indexes S100b of brain
injury [(0.9 ± 0.1) mg/L] and NSE [(10.7 ± 1.3) mg/mL] of pa-
tients in the Group A were also distinctly lower than those
[(1.3 ± 0.2) mg/L and (15.3 ± 1.7) mg/mL, respectively] in NC
group (P < 0.05).
3.3. Serum biochemical index
On 24 h after surgery, ESR [(11.7 ± 2.5) mm/h], CRP
[(2.3 ± 0.4) mg/L], BUN [(10.7 ± 1.2) mmol/L] and Cr
[(151.6 ± 14.9) mmoL] in patients of Group A were all signiﬁ-
cantly lower than those [(23.6 ± 3.8) mm/h, (6.9 ± 1.1) mg/L,
(16.7 ± 1.7) mmol/L and (192.5 ± 18.3) mmol/L, respectively] in
patients of NC group. The differences of AST, ALT, CK and
CK-MB between two groups showed no statistical signiﬁcance
(Table 1).
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Patients with diabetes complicated with cerebral hemorrhage
are common in clinic. Interventional therapy has been proved to
be an effective way to treat the disease. CT scan was used to
determine the hematoma, and then a blunt needle core was
placed in the hematoma slowly to suck and wash in order to
eliminate the hematoma by haemostatic. During the interven-
tional therapy of cerebral hemorrhage, situations such as cyclic
drastic ﬂuctuations, normal brain tissue injuries around the
hemorrhage site and important organ dysfunctions may happen.
Therefore, how to improve safety for patients during anesthesia
and surgery has been the key point of clinical researches at
present[6,7]. Dexmedetomidine is a kind of a2 receptor agonist of
high selectivity. The receptor selectivity (a2:a1) is 1620:1. It has
a role to play in sedation, analgesia, anti-anxiety and anti-sym-
pathetic nerve activity, and it can also inhibit the increase of
plasma catecholamine caused by surgical stimulation, which is
conductive to the stability of haemodynamics in anesthesia[8,9].
Dexmedetomidine is applied successfully in many general
surgery operations. It was explained elaborately in this study
whether it works positively in treatments of neurosurgery such
as cerebral hemorrhage operation.
Secondary anoxia would often happen followed by cerebral
hemorrhage in patients with diabetes mellitus type 2, which
aggravated brain injury. After cerebral hemorrhage happened,
due to pathologic change such as cerebrovascular injury and
cerebral ischemia and anoxia, a large amount of free radicals
were produced by in vivo xanthine oxidase system and arach-
idonic acid metabolism to strengthen lipid peroxidation and
damage biological membrane[10]. Dexmedetomidine can protect
the brain injury by decreasing its anti-sympathetic nerve activ-
ity, anti-inﬂammation, anti-oxidation and anti-apoptosis and
improving the balance of cerebral oxygen supply and con-
sumption during the period of ischemia. Traditional concepts
claim that the nerve protection function is related to the inhibited
locus coeruleus-eliminated methylepinephrine neuronal excita-
tion, which worked by inﬂuencing the inset of action potential
and releasing neurotransmitter[11,12]. The latest research states that
a2 adrenaline receptor sub-types can protect the nerve. Intra-
cerebral a2 adrenaline receptors gather in pons participating in
the transmission of the sympathetic nerve signals from the main
center to peripheral region. S100b proteins mainly distribute to
the central nervous system and NSE speciﬁcity exists in neuron
and neuroendocrine cells. After the neuron is damaged, S100b
and NSE can be produced in abundance, which serves as a
sensitive index for central nervous system injury[13–15]. It was
found in the analysis of the contents of postoperative serum
and cerebrospinal ﬂuid related factors of patients with diabetes
mellitus type 2 complicated with cerebral hemorrhage that on
24 h after surgery, the contents of S100b and NSE of patients
treated with dexmedetomidine were decreased signiﬁcantly. It
could be concluded that dexmedetomidine played a protective
role in treating cerebral hemorrhage during interventional
therapy. It could reduce brain function injury for patients by
decreasing neuron damage and increasing expressions of
multiple growth factors[16,17].
CRP is the earliest inﬂammatory factor which appears in post-
traumatic stress responses. Its great expression and release are
closely related to the formation of encephaledema, destruction ofblood-brain barrier and nerve degeneration[18]. The serum level of
CRP can reﬂect the injury degree of brain tissues sensitively. The
value of ESR was related to plasma viscosity, especially the
cohesion between red blood cells. The stronger in the cohesion
between red blood cells is, the higher the ESR is. All kinds of
inﬂammations and tissue injury can accelerate ESR for patients.
That is the inescapable consequence of the copious secretions of
inﬂammatory factors including CRP, which can reﬂect the
injury degree of cerebral hemorrhage operation indirectly[19].
After detecting the postoperative levels of ESR and CRP of
patients in the two groups, it was found that the levels of
postoperative ESR and CRP in patients of Group A were pretty
low, which was related to the sedative and analgesic effects
induced by dexmedetomidine through activating post-synaptic
receptor. Dexmedetomidine could decrease sympathomimetic
activity overall and inhibit the surgery-stimulated excitability of
the sympathetic nervous system effectively[20–22].
When cerebral hemorrhage happens in patients with diabetes, it
may cause concomitant injuries of important organ functions such
as heart, liver and kidney, which might be related to the changes of
multiple hormones levels in the body circulation. No signiﬁcant
differences have been found in the detection of the early post-
operativemyocardial enzymes indexes (CK and CK-MB) and liver
function indexes (ALT and AST) of the two groups, which indi-
cated that the application of dexmedetomidine in anesthesia could
not inﬂuence the heart and liver functions distinctly[23]. Many
domestic and abroad researches revealed that patients with acute
cerebral hemorrhage may be accompanied with different degrees
of decreased glomerular ﬁltration rates, which has something to
do with the renal ischemia injury. Renal ischemia injury is
mainly caused by hypovolemia due to dehydration and limited
liquid intake after cerebral hemorrhage interventional treatment. In
interventional treatment of cerebral hemorrhage, mannitol, a com-
monly used dehydrating agent, could injury kidneys slightly[10].
When cerebral hemorrhage involved in hypothalamic-pituitary-
adrenocortical system, which can increase diencephalon, rennin-
angiotensin and thrombokinase and decrease glomerular ﬁltration
rate and neurons renal dysfunctionmay occur[24–26]. BUN andCr are
the commonest indexes reﬂecting renal function in clinic and they
can embody the glomerular ﬁltration effect. The latest study has
shown that dexmedetomidine, to some degree, can protect renal
functions. In this study, it was found in the detection of
postoperative early renal function indexes in patients of the two
groups that the values of serum BUN and Cr in patients treated
with dexmedetomidine during operation are lower. It could be
concluded that dexmedetomidine can protect renal function to
some extend in interventional treatment of cerebral hemorrhage
for patients with diabetes mellitus type 2. The renal function
protection effect of dexmedetomidine may be related to its anti-
sympathetic nerve activity, glomerular ﬁltration rate improve-
ment, reduction of the release of sympathetic-mediated renal pre-
synaptic norepinephrine[27–29].
In conclusion, the application of dexmedetomidine in the
interventional therapy in patients with diabetes mellitus type 2
complicated with acute cerebral hemorrhage could protect brain
and renal functions and reduce systemic inﬂammatory responses.
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